Shivani Nyati, Head of Wealth at Swastika Investmart Ltd., mentioned that Emcure Pharmaceuticals Ltd. is expected to have a strong debut on the stock market, with the IPO generating significant interest. The grey market premium (GMP) of Rs 372 reflects a 36.9% premium over the issue price, suggesting a listing pop of around 35-37%. Nyati also noted that the IPO saw an impressive subscription rate of 67.87 times, indicating strong investor confidence.
IPO screener: Emcure Pharma listing today (The Hindu Business Line)Emcure Pharma IPO shares to make stock market debut today; strong listing gains likely (Business Today)Emcure Pharma IPO listing tomorrow: Will it have strong market debut? (India Today)Emcure Pharma IPO listing tomorrow: Will it have strong market debut? (MSN)Emcure Pharma IPO shares to make stock market debut today; strong listing gains likely (MSN)Emcure Pharma to make stock market debut on Wednesday; here's what to expect as GMP corrects (MSN)
